Researchers Database

UZUKA TAKEO

Affiliation: Department of Neurologic Surgery
Position: Associate Professor
Last Updated :2025/06/23

Profiles

Profiles

  • 氏名

    UZUKA TAKEO

Affiliation

  • Department of Neurologic Surgery, Associate Professor

Research achievements

Published Papers

    Original paper
  • So-called bifocal tumors with diabetes insipidus and negative tumor markers: are they all germinoma?, Kanamori Masayuki;Takami Hirokazu;Yamaguchi Shigeru;Sasayama Takashi;Yoshimoto Koji;Tominaga Teiji;Inoue Akihiro;Ikeda Naokado;Kambe Atsushi;Kumabe Toshihiro;Matsuda Masahide;Tanaka Shota;Natsumeda Manabu;Matsuda Ken-Ichiro;Nonaka Masahiro;Kurihara Jun;Yamaoka Masayoshi;Kagawa Naoki;Shinojima Naoki;Negoto Tetsuya;Nakahara Yukiko;Arakawa Yoshiki;Hatazaki Seiji;Shimizu Hiroaki;Yoshino Atsuo;Abe Hiroshi;Akimoto Jiro;Kawanishi Yu;Suzuki Tomonari;Natsume Atsushi;Nagane Motoo;Akiyama Yukinori;Keino Dai;Fukami Tadateru;Tomita Takahiro;Kanaya Kohei;Tokuyama Tsutomu;Izumoto Shuichi;Nakada Mitsutoshi;Kuga Daisuke;Yamamoto Shohei;Anei Ryogo;Uzuka Takeo;Fukai Junya;Kijima Noriyuki;Terashima Keita;Ichimura Koichi;Nishikawa Ryo, Neuro-oncology, 23(2), 295-303, 2021
  • Gene expression profiling of 19q-loss astrocytomas suggest a specific pattern associated with the better prognosis., Otani Ryohei;Mukasa Akitake;Uzuka Takeo;Higuchi Fumi;Matsuda Hadzki;Nomura Masashi;Tanaka Shota;Kim Phyo;Ueki Keisuke, Journal of neuro-oncology, 154(2), 221-228, Sep. 2021
  • Bevacizumab beyond Progression for Newly Diagnosed Glioblastoma (BIOMARK): Phase II Safety, Efficacy and Biomarker Study., Nagane Motoo;Ichimura Koichi;Onuki Ritsuko;Narushima Daichi;Honda-Kitahara Mai;Satomi Kaishi;Tomiyama Arata;Arai Yasuhito;Shibata Tatsuhiro;Narita Yoshitaka;Uzuka Takeo;Nakamura Hideo;Nakada Mitsutoshi;Arakawa Yoshiki;Ohnishi Takanori;Mukasa Akitake;Tanaka Shota;Wakabayashi Toshihiko;Aoki Tomokazu;Aoki Shigeki;Shibui Soichiro;Matsutani Masao;Ishizawa Keisuke;Yokoo Hideaki;Suzuki Hiroyoshi;Morita Satoshi;Kato Mamoru;Nishikawa Ryo, Cancers, 14(22), 10 Nov. 2022
    Unclear
  • Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group., Motomura Kazuya;Sasaki Keita;Sugii Narushi;Yamaguchi Shigeru;Inoue Hirotaka;Oshima Akito;Tanaka Kazuhiro;Otani Yoshihiro;Shirahata Mitsuaki;Shibahara Ichiyo;Nagane Motoo;Tsuzuki Shunsuke;Matsutani Tomoo;Tsukamoto Yoshihiro;Kijima Noriyuki;Asano Kenichiro;Ohno Makoto;Inoue Akihiro;Mineharu Yohei;Miyake Keisuke;Mitobe Yuta;Hanihara Mitsuto;Kawanishi Yu;Deguchi Shoichi;Saito Masato;Matsuda Ryosuke;Ujifuku Kenta;Arita Hideyuki;Sato Yuichi;Yamashita Shinji;Yonezawa Ushio;Yamaguchi Junya;Momii Yasutomo;Ogawa Takahiro;Kambe Atsushi;Ohba Shigeo;Fukai Junya;Saito Norihiko;Kinoshita Masashi;Sumi Koichiro;Otani Ryohei;Uzuka Takeo;Takebe Noriyoshi;Koizumi Shinichiro;Saito Ryuta;Arakawa Yoshiki;Narita Yoshitaka; , Japanese journal of clinical oncology, 54(10), 1123-1131, 03 Oct. 2024
  • Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas., Nakashima Takuma;Yamamoto Ryo;Ohno Makoto;Sugino Hirokazu;Takahashi Masamichi;Funakoshi Yusuke;Nambu Shohei;Uneda Atsuhito;Yanagisawa Shunsuke;Uzuka Takeo;Arakawa Yoshiki;Hanaya Ryosuke;Ishida Joji;Yoshimoto Koji;Saito Ryuta;Narita Yoshitaka;Suzuki Hiromichi, Brain tumor pathology, 41(2), 50-60, 08 Feb. 2024
  • Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment., Higuchi Fumi;Uzuka Takeo;Matsuda Hadzki;Sumi Takuma;Iwata Kayoko;Namatame Takashi;Shin Masahiro;Akutsu Hiroyoshi;Ueki Keisuke, Brain tumor pathology, 41(2), 80-84, 31 Jan. 2024


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.